Wolf CR - Search Results

1

Daly AK, Brockmöller J, Broly F, Eichelbaum M, Evans WE, Gonzalez FJ, Huang JD, Idle JR, Ingelman-Sundberg M, Ishizaki T, Jacqz-Aigrain E, Meyer UA, Nebert DW, Steen VM, Wolf CR, Zanger UM. Daly AK, et al. Among authors: wolf cr. Pharmacogenetics. 1996 Jun;6(3):193-201. doi: 10.1097/00008571-199606000-00001. Pharmacogenetics. 1996. PMID: 8807658

2

Nomenclature for alleles of the cytochrome P450 oxidoreductase gene.

Sim SC, Miller WL, Zhong XB, Arlt W, Ogata T, Ding X, Wolf CR, Flück CE, Pandey AV, Henderson CJ, Porter TD, Daly AK, Nebert DW, Ingelman-Sundberg M. Sim SC, et al. Among authors: wolf cr. Pharmacogenet Genomics. 2009 Jul;19(7):565-6. doi: 10.1097/FPC.0b013e32832af5b7. Pharmacogenet Genomics. 2009. PMID: 19535965 Free PMC article. No abstract available.

3

Alternative splicing in the human cytochrome P450IIB6 gene: use of a cryptic exon within intron 3 and splice acceptor site within exon 4.

Miles JS, McLaren AW, Gonzalez FJ, Wolf CR. Miles JS, et al. Among authors: wolf cr. Nucleic Acids Res. 1990 Jan 11;18(1):189. doi: 10.1093/nar/18.1.189. Nucleic Acids Res. 1990. PMID: 2308828 Free PMC article. No abstract available.

4

Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coli.

Pritchard MP, Glancey MJ, Blake JA, Gilham DE, Burchell B, Wolf CR, Friedberg T. Pritchard MP, et al. Among authors: wolf cr. Pharmacogenetics. 1998 Feb;8(1):33-42. doi: 10.1097/00008571-199802000-00005. Pharmacogenetics. 1998. PMID: 9511179

5

Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6.

Worrall SF, Corrigan M, High A, Starr D, Matthias C, Wolf CR, Jones PW, Hand P, Gilford J, Farrell WE, Hoban P, Fryer AA, Strange RC. Worrall SF, et al. Among authors: wolf cr. Pharmacogenetics. 1998 Oct;8(5):433-9. doi: 10.1097/00008571-199810000-00008. Pharmacogenetics. 1998. PMID: 9825835

6

Identification of the primary gene defect at the cytochrome P450 CYP2D locus.

Gough AC, Miles JS, Spurr NK, Moss JE, Gaedigk A, Eichelbaum M, Wolf CR. Gough AC, et al. Among authors: wolf cr. Nature. 1990 Oct 25;347(6295):773-6. doi: 10.1038/347773a0. Nature. 1990. PMID: 1978251

7

Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer.

Wadelius M, Autrup JL, Stubbins MJ, Andersson SO, Johansson JE, Wadelius C, Wolf CR, Autrup H, Rane A. Wadelius M, et al. Among authors: wolf cr. Pharmacogenetics. 1999 Jun;9(3):333-40. doi: 10.1097/00008571-199906000-00008. Pharmacogenetics. 1999. PMID: 10471065

8

CYP2D6 genotyping and the association with lung cancer susceptibility.

Wolf CR, Smith CA, Bishop T, Forman D, Gough AC, Spurr NK. Wolf CR, et al. Pharmacogenetics. 1994 Apr;4(2):104-6. doi: 10.1097/00008571-199404000-00008. Pharmacogenetics. 1994. PMID: 8081411 No abstract available.

9

Genetic analysis of the human cytochrome P450 CYP2C9 locus.

Stubbins MJ, Harries LW, Smith G, Tarbit MH, Wolf CR. Stubbins MJ, et al. Among authors: wolf cr. Pharmacogenetics. 1996 Oct;6(5):429-39. doi: 10.1097/00008571-199610000-00007. Pharmacogenetics. 1996. PMID: 8946475

10

Cytochrome P450 CYP2D6.

Wolf CR, Smith G. Wolf CR, et al. IARC Sci Publ. 1999;(148):209-29. IARC Sci Publ. 1999. PMID: 10493260 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

518 results

Search Page